Dr. Falk Pharma

Dr. Falk Pharma company information, Employees & Contact Information

Explore related pages

Related company profiles:

Dr. Falk Pharma GmbH has been developing and marketing innovative medicines to treat a wide range of gastrointestinal disorders like inflammatory bowel disease or eosinophilic esophagitis as well as hepatobiliary disorders such as primary biliary cholangitis for over 60 years. As the international experts in digestive and metabolic medicine, we bring together physicians, scientists, and patients to devise new and powerful approaches to patient care. Our company engages in pre-clinical and clinical stage research that aims to meaningfully improve therapeutic practice as well as patient health and well-being. We are a family-owned business with a global presence, we have ten affiliates in Europe and Australia and are continuously growing. Our company has its headquarters and R&D facilities in Freiburg, Germany, and our pharmaceutical products are manufactured in Europe, mainly at sites in Germany, France, Italy and Switzerland. Dr. Falk Pharma GmbH employs approximately 1,400 individuals globally, of those 340 in Freiburg. Imprint: https://drfalkpharma.com/en/imprint/ Social Media Guidelines: https://drfalkpharma.com/en/social-media-guidelines/

Company Details

Employees
336
Address
Leinenweberstraße 5, Freiburg Im Breisgau,baden-Württemberg 79108,germany
Phone
++49 / (0)761 / 1514-0
Email
ze****@****arma.de
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Freiburg im Breisgau, Baden-Württemberg
Looking for a particular Dr. Falk Pharma employee's phone or email?

Dr. Falk Pharma Questions

News

Dr Falk Pharma and Allianthera sign agreement for ATB102 - Pharmaceutical Technology

Dr Falk Pharma and Allianthera sign agreement for ATB102 Pharmaceutical Technology

Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals - GlobeNewswire

Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals GlobeNewswire

Dr. Falk Pharma’s PSC drug achieves endpoints in Phase III trial - Clinical Trials Arena

Dr. Falk Pharma’s PSC drug achieves endpoints in Phase III trial Clinical Trials Arena

Dr. Falk Pharma and Allianthera (Suzhou) Biopharma to develop treatment for Ulcerative Colitis - BioSpectrum Asia

Dr. Falk Pharma and Allianthera (Suzhou) Biopharma to develop treatment for Ulcerative Colitis BioSpectrum Asia

Dr. Falk Pharma announces positive results from its pivotal - GlobeNewswire

Dr. Falk Pharma announces positive results from its pivotal GlobeNewswire

University of Edinburgh spinout Kynos Therapeutics acquired by Dr. Falk Pharma - Pharmafile

University of Edinburgh spinout Kynos Therapeutics acquired by Dr. Falk Pharma Pharmafile

Prometheus Biosciences and Dr. Falk Pharma GmbH Announce Global Collaboration Agreement to Develop and Commercialize a Novel IBD Antibody - PR Newswire

Prometheus Biosciences and Dr. Falk Pharma GmbH Announce Global Collaboration Agreement to Develop and Commercialize a Novel IBD Antibody PR Newswire

Pediatric non-alcoholic steatohepatitis: The first report on the ultrastructure of hepatocyte mitochondria - Baishideng Publishing Group

Pediatric non-alcoholic steatohepatitis: The first report on the ultrastructure of hepatocyte mitochondria Baishideng Publishing Group

Top Dr. Falk Pharma Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant